Key result
Repetitive pulsed field applications achieve 100% durable PV isolation versus single applications.
Why the study?
Preclinical studies showed pulsed field ablation lesion dimensions increase with repetitive applications, but whether pulmonary vein isolation durability varies with single vs repetitive applications was unknown.
Does repetitive pulsed field application improve pulmonary vein isolation durability compared to single application in patients with atrial fibrillation?
Does repetitive pulsed field application improve pulmonary vein isolation durability compared to single application in patients with atrial fibrillation?
Answers are grounded in this paper and cite their sources.
In a first-in-human trial, repetitive pulsed field applications using a spherical array catheter significantly improved the durability of pulmonary vein isolation compared to a single application.
BACKGROUND: Preclinical studies have revealed that pulsed field ablation (PFA) lesion dimensions increase with repetitive applications at a similar electric field. OBJECTIVES: This study investigated whether pulmonary vein isolation (PVI) durability varies with single vs repetitive pulsed field (PF) applications. METHODS: Atrial fibrillation patients underwent PVI using a spherical multielectrode array PFA catheter delivered with a 19-F deflectable sheath under intracardiac echocardiographic guidance. Esophagogastroduodenoscopy and brain magnetic resonance imaging were performed within 1 to 3 days, and invasive remapping at ∼2 to 3 months. RESULTS: The patient cohort (n = 21; age 63 ± 11 years; 67% women) underwent PVI in either of 2 groups: group 1 (n = 11)-single PF application/PV; and group 2 (n = 10)-3 PF applications/PV. In both groups, PVI was acutely successful in all (100%) patients. Despite significantly longer pulse delivery times (75.2 ± 7.4 s/patient vs 24.5 ± 5.5 s/patient) the procedure times (73.2 ± 13.7 minutes vs 93.7 ± 18.5 minutes) were shorter with group 2 vs group 1. There was no stroke/transient ischemic attack, pericardial effusion, phrenic nerve injury, or esophageal complications. Esophagogastroduodenoscopy was normal in both groups of patients (n = 9). Screening brain magnetic resonance imaging revealed asymptomatic cerebral lesions (diffusion weighted imaging+/fluid attenuated inversion recovery-) in 3 of 16 (18.7%) patients. PV remapping revealed durable PVI in 62.5% PVs in group 1 (n = 10), compared with all 100% PVs in group 2 (n = 9); this translates to all PVs being durably isolated in 30% vs 100% (P < 0.05) of patients in groups 1 and 2, respectively. CONCLUSIONS: In his first-in-human trial, the "single-shot" spherical array PFA catheter was shown to safely isolate PVs. Repetitive PF application is key for lesion consolidation to maximize PVI durability.
No takes yet. Share an insight, caveat, or question.
Turagam et al. (2023) studied Atrial fibrillation (n=21). Spherical multielectrode array PFA catheter vs. Single PF application/PV was evaluated on All PVs durably isolated per patient (p=< 0.05). Repetitive pulsed field applications (3 per PV) using a spherical array catheter achieved 100% durable pulmonary vein isolation per patient compared to 30% with a single application (P<0.05).
Synapse has enriched 10 related papers. Consider them for comparative context: